India is likely to clear the Oxford vaccine against Covid-19 this week. The expert committee of the Central Drugs Standard Control Organisation is likely to meet sometime this week to examine Serum Institute of India’s emergency-use authorisation application for Oxford-AstraZeneca’s vaccine against coronavirus disease, the Hindustan Times has reported quoting government sources. Serum Institute, which is manufacturing and testing the Oxford-AstraZeneca coronavirus vaccine in India, last week had submitted additional data to the national drugs regulator that it had sought on December 9. It is likely that Oxford-AstraZeneca vaccine candidate may be the first anti-Covid-19 vaccine to be granted emergency-use approval in India.